Indian Generic Medicines Unaffected by Trump's 100% Pharmaceutical Import Tariff

Sep 26, 2025 05:57 pm CST

President Trump's new 100% tariff on pharmaceutical imports targets only patented and branded products, leaving Indian generic medicines unaffected according to the Indian Pharmaceutical Alliance. With Indian companies supplying 47% of US pharmaceutical needs and generating $219 billion in healthcare savings in 2022 alone, industry leaders remain confident in their market position as they continue providing affordable medications to American consumers.